Company news
Immunotech Biopharm Ltd news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 31 October 2026
November 2, 2026
Placing of new shares under general mandate
October 27, 2026
Monthly Return of Equity Issuer on Movements in Securities for the Month Ended 30 September 2026
October 5, 2026
Supplemental announcement to the annual report for the year ended 31 December 2025
September 30, 2026
2026 Interim report
September 18, 2026
Major transaction further delay in despatch of circular in relation to the construction of the new biological drug R&D and industrialisation based in beijing
May 13, 2021
Major transaction delay in despatch of circular in relation to the construction of the new biological drug R&D and industrialisation based in beijing
April 22, 2021
Change of senior management
April 13, 2021
Immunotech Biopharm: Major transaction construction agreement in relation to the construction of the new biological drug R&D and industrialisation base in beijing
March 29, 2021
Voluntary announcement establishment of and investment in cellular immunotherapy specialised industry fund as a limited partner
February 24, 2021